Key result
MAVS over-expression inhibits CVB3 replication and cell death by enhancing type I interferon production.
Why the study?
MAVS protein plays an essential role in inhibiting CVB3 infection through type I IFN pathway, but the protective effect of MAVS over-expression against CVB3 infection and its mechanism remain to be explored.
Over-expression of MAVS protects against coxsackievirus B3 infection in vitro by enhancing type I interferon production, suggesting a potential therapeutic target for CVB3-related syndromes such as viral myocarditis.
BACKGROUND: Recent studies have revealed that Mitochondrial Antiviral Signaling (MAVS) protein plays an essential role in the inhibition of viral infection through type I interferon (IFN) pathway. It has been shown that 3C (pro) cysteine protease of coxsackievirus B3 (CVB3) cleaves MAVS to inhibit type I IFNs induction. Other workers also found that MAVS knock-out mice suffered CVB3 susceptibility and severe histopathological change. Accordingly,our experiments were designed to explore the protection of over-expressing MAVS against CVB3 infection and the possible mechanism. RESULTS: In this study, HeLa cells (transfected with MAVS constructs pre- or post- exposure to CVB3) were used to analyze the function of exogenous MAVS on CVB3 infection. The results revealed that though CVB3 infection induced production of type I IFNs, viral replication and cell death were not effectively inhibited. Similarly, exogenous MAVS increased type I IFNs moderately. Morever, we observed robust production of type I IFNs in CVB3 post-infected HeLa cells thereby successfully inhibiting CVB3 infection, as well formation of cytopathic effect (CPE) and cell death. Finally, introduction of exogenous MAVS into CVB3 pre-infected cells also restricted viral infection efficiently by greatly up-regulating IFNs. CONCLUSIONS: In summary, exogenous MAVS effectively prevents and controls CVB3 infection by modulating and promoting the production of type I IFNs. The IFNs level in MAVS over-expressing cells is still tightly regulated by CVB3 infection. Thus, the factors that up-regulate MAVS might be an alternative prescription in CVB3-related syndromes by enhancing IFNs production.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2012) studied Coxsackievirus B3 infection. Exogenous MAVS over-expression vs. Empty vector was evaluated on CVB3 replication and cell viability. Over-expression of exogenous MAVS in HeLa cells effectively inhibited coxsackievirus B3 replication and cell death by robustly enhancing the production of type I interferons.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: